Rein Therapeutics Inc (RNTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 65,112 | 16,276 | 27,647 | 26,605 | 20,496 |
| Operating Income | -65,112 | -16,276 | -27,647 | -26,605 | -20,496 |
| Other Income | 685 | 544 | 318 | 441 | -661 |
| Pre-tax Income | -64,427 | -15,732 | -27,329 | -26,164 | -21,157 |
| Income Tax | -1,544 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -62,883 | -15,732 | -27,329 | -26,164 | -21,157 |
| Net Income | $-62,883 | $-15,732 | $-27,329 | $-26,164 | $-21,157 |
| EPS Basic Total Ops | -3.51 | -3.42 | -6.02 | -5.89 | -12.20 |
| EPS Basic Continuous Ops | -3.51 | -3.42 | -6.02 | -5.89 | -12.14 |
| EPS Diluted Total Ops | -3.51 | -3.42 | -6.02 | -5.89 | -12.20 |
| EPS Diluted Continuous Ops | -3.51 | -3.42 | -6.02 | -5.89 | -12.14 |
| EPS Diluted Before Non-Recurring Items | -1.53 | -3.20 | -6.02 | -5.80 | -12.20 |
| EBITDA(a) | $-28,049 | $-16,125 | $-27,686 | $-26,244 | $-20,342 |